Shiseido: China Exposure, Potential Earnings Misses and Write-Offs Create Additional Downside Risk
We think that there’s still considerable downside risk to Shiseido in the short term, especially with the company’s exposure to the worsening China...
260 Views
Giant Biogene Pre-IPO - Thoughts on Valuation
Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.
228 Views
Japanese Cosmetics: Trading Around Q3 Earnings
The latest rally in Japanese cosmetics, driven by improving domestic market conditions has strangely avoided two of the big names in the market,...
230 Views
Shiseido: Drunk Elephant Seems an $845m Write-Off
The #barewithus🐘 movement, rarely gets any new selfies posted and the Drunk Elephant Instagram page follower growth is now around less than 1/4th...
411 Views
Japan Tourism | 3 Stocks to Buy for Open Borders
Japan has been slow to reopen its borders post COVID. Under pressure to stimulate the economy, Kishida has committed to lifting the cap on...
268 Views